HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amelioration of cerebral infarction and improvement of neurological deficit by a Korean herbal medicine, modified Bo-Yang-Hwan-O-Tang.

AbstractOBJECTIVES:
Modified Bo-Yang-Hwan-O-Tang (mBHT) is an improved herbal formula of BHT, which has been widely used to treat ischaemic stroke in East Asia, by the addition of five herbs having anti-ischaemic properties. In this study, we investigated whether mBHT would reduce cerebral ischaemic injury in rats.
METHODS:
Sprague-Dawley rats were subjected to a 90-min middle cerebral artery occlusion (MCAO) and subsequent 22-h reperfusion. mBHT was administered either intraperitoneally twice 15 min before and 15 min after, or orally once 30 min or 120 min after the onset of MCAO (50 or 200 mg/kg each).
KEY FINDINGS:
Intraperitoneal administration of mBHT markedly reduced the cerebral infarct size and neurological deficit caused by MCAO/reperfusion. mBHT treatment also significantly improved long-term survival rate after cerebral ischaemic injury. Oral administration of mBHT 30 min after ischaemia also markedly reduced the infarct size after cerebral ischaemia. The anti-ischaemic effect of mBHT was significantly, but not fully, reduced when mBHT-induced hypothermia was abolished. In cultured cortical neurons, we further found that mBHT decreased oxygen-glucose deprivation/re-oxygenation-evoked neuronal injury by inhibiting production of reactive oxygen species, decrease in mitochondrial transmembrane potential, and activation of caspase-3. However, mBHT did not inhibit N-Methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity.
CONCLUSIONS:
Taken together, our data suggest that mBHT has multiple anti-ischaemic properties and would be a good therapeutic herbal prescription for the treatment of cerebral ischaemic stroke.
AuthorsYookeum Choi, Seul-Ki Kim, In-Young Choi, Chung Ju, Kung-Woo Nam, Sunyoung Hwang, Byung-Woo Kim, Min Ji Yoon, Moo-Ho Won, Yong-Ki Park, Won-Ki Kim
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 63 Issue 5 Pg. 695-706 (May 2011) ISSN: 2042-7158 [Electronic] England
PMID21492172 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 The Authors. JPP © 2011 Royal Pharmaceutical Society.
Chemical References
  • Plant Extracts
  • Reactive Oxygen Species
  • bo-yang-hwan-o-tang
  • Caspase 3
  • Glucose
  • Oxygen
Topics
  • Animals
  • Brain Ischemia (drug therapy)
  • Caspase 3 (metabolism)
  • Cells, Cultured
  • Cerebral Infarction (complications, metabolism, prevention & control)
  • Cerebrum (cytology, drug effects, metabolism)
  • Cognition Disorders (etiology, metabolism, prevention & control)
  • Glucose (metabolism)
  • Hypothermia, Induced
  • Infarction, Middle Cerebral Artery
  • Male
  • Medicine, Korean Traditional
  • Membrane Potential, Mitochondrial (drug effects)
  • Neurons (drug effects, metabolism)
  • Oxygen (metabolism)
  • Phytotherapy
  • Plant Extracts (pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (antagonists & inhibitors)
  • Reperfusion Injury (complications, metabolism, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: